CEO Interview
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
PGX Technology
PGX technology is a novel spray drying technique for processing water-soluble biopolymers which utilizes the unique and tunable properties of Pressurized Gas eXpanded liquids.
Learn More About PGX
Stock Information
TSX Venture
CZO
Change
Volume
Day Range
52 Week Range
Corporate Presentation
View our latest corporate presentation to learn more about Ceapro, our products and our proprietary manufacturing technology.
View Presentation
Products
Ceapro isolates ingredients from oat products, such as Avenanthramides and Beta Glucan, and botanical products to naturally enhance popular cosmetic and personal care products.
View Our Products
Latest News
Ceapro Announces Results of 2019 Shareholders’ Meeting
Jun 10, 2019 | Read More
Ceapro Presents Positive Results from Avenanthramides Study at the 2019 American Society of Sports Medicine Meeting
Jun 5, 2019 | Read More
Ceapro Inc. Commences Patient Enrollment in First-in-Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent
Jun 3, 2019 | Read More
Ceapro Inc. Reports 2019 First Quarter Financial Results and Highlights
May 23, 2019 | Read More